Skip to content
Boca Raton City Online – Lifestyle
Author:
Egetis Therapeutics
Egetis Therapeutics Announces U.S. FDA Approval of EMCITATE® (tiratricol) for Patients with MCT8 Deficiency
September 29, 2026
Egetis Therapeutics to Participate in Upcoming Investor Conferences in September
September 3, 2026
Egetis Therapeutics Announces National Re-Airing of Behind the Mystery Episode on Lifetime Spotlighting MCT8 Deficiency
June 10, 2026
Egetis to Present Healthcare Resource Drivers and Cost in MCT8 Deficiency at ISPOR 2026
May 19, 2026
Egetis Announces Grant of Patent for MCT8 Deficiency Composition in The U.S.
May 5, 2026
Egetis Therapeutics to Participate in Pediatric Endocrine Society Annual Meeting 2026
April 30, 2026
Egetis Appoints Tiago Nunes as Chief Medical Officer
April 9, 2026